Kevin Barton, MD


Associate Professor

Languages Spoken


Clinical Expertise

  • Amyloidosis
  • Cancers of the Blood and Blood Cells
  • Leukemia
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
  • Refractory Lymphoma
  • Relapsed Lymphoma
  • Brain Tumors

Medical Education

Medical School
The Ohio State University College of Medicine and Public Health
University of Chicago Hospitals and Clinics - Internal Medicine: General
University of Chicago Hospitals and Clinics - Internal Medicine: Hematology & Medical Oncology

Board Certification

Hematology - Subspecialty Cert: AM Board of Internal Medicine
Internal Medicine - General Cert: AM Board of Internal Medicine


  • Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313 Persky, D. O.; Miller, T. P.; Unger, J. M.; Spier, C. M.; Puvvada, S.; Stea, B. D.; Press, O. W.; Constine, L. S.; Barton, K. P.; Friedberg, J. W.; LeBlanc, M.; Fisher, R. I., Blood
  • Heckathorn disease revisited Nand, S.; Barton, K.; Schultz, R.; Klein, M.; Kini, A., Blood
  • Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma Stiff, P. J.; Unger, J. M.; Cook, J. R.; Constine, L. S.; Couban, S.; Stewart, D. A.; Shea, T. C.; Porcu, P.; Winter, J. N.; Kahl, B. S.; Miller, T. P.; Tubbs, R. R.; Marcellus, D.; Friedberg, J. W.; Barton, K. P.; Mills, G. M.; LeBlanc, M.; Rimsza, L. M.; Forman, S. J.; Fisher, R. I., The New England journal of medicine
View All ResearchShow Less
  • Management of diffuse low-grade cerebral gliomas. Prabhu, V.; Khaldi, A.; Barton, K.; Melian, E.; Schneck, M. J.; Primeau, M.; Lee, J. M., Neurology Clinics
  • Precursor B-cell acute lymphoblastic leukaemia with FAB L3 (i.e. Burkitt's leukaemia/lymphoma) morphology and co-expression of monoclonal surface light chains and Tdt: report of a unique case and review of the literature, Higa, B.; Alkan, S.; Barton, K.; Velankar, M., Pathology
  • Hydroxyurea azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial, Nand, S.; Godwin, J.; Smith, S.; Barton, K.; Michaelis, L.; Alkan, S.; Veerappan, R.; Rychlik, K.; Germano, E.; Stiff, P., Leukemia & lymphoma
  • Thrombotic microangiopathy associated with sunitinib a VEGF inhibitor, in a patient with factor V Leiden mutation., Levey, S. A.; Bajwa, R. S.; Picken, M. M.; Clark, J. I.; Barton, K.; Leehey, D. J., NDT Plus
  • Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge Nand, S.; Barton, K., Leukemia & lymphoma
  • Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Kapur, U.; Barton, K.; Fresco, R.; Leehey, D. J.; Picken, M. M., Archives of Pathology & Laboratory Medicine
  • Management of scalp toxic epidermal necrolysis and cranial osteomyelitis with serratus anterior myocutaneous pedicle flap: a case report. Levitt, M. R.; Benedict, W. J.; Barton, K.; Melian, E.; Gamelli, R. L.; Vandevender, D.; Rosseau, G.; Prabhu, V. C., Journal of Burn Care & Research
  • Recurrent strokes in two patients with POEMS syndrome and Castleman's disease. Garcia, T.; Dafer, R. M.; Hocker, S.; Schneck, M.; Barton, K.; Biller, J., Journal of Stroke & Cerebrovascular Diseases
  • A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. Naeem, M.; Harrison, K.; Barton, K.; Nand, S.; Alkan, S., European journal of haematology
  • Ets-1 deficiency leads to altered B cell differentiation hyperresponsiveness to TLR9 and autoimmune disease, Wang, D.; John, S. A.; Clements, J. L.; Percy, D. H.; Barton, K. P.; Garrett-Sinha, L. A., International immunology
  • Transcriptional regulation of CD1D1 by Ets family transcription factors Geng, Y.; Laslo, P.; Barton, K.; Wang, C. R., Journal of immunology (Baltimore, Md.: 1950)
  • Analysis of histone deacetylase inhibitor depsipeptide (FR901228), effect on multiple myeloma., Khan, S. B.; Maududi, T.; Barton, K.; Ayers, J.; Alkan, S., British journal of haematology
  • Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Houde, C.; Li, Y.; Song, L.; Barton, K.; Zhang, Q.; Godwin, J.; Nand, S.; Toor, A.; Alkan, S.; Smadja, N. V.; Avet-Loiseau, H.; Lima, C. S.; Miele, L.; Coignet, L. J., Blood